The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
New advances in the diagnosis and management of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma is one of the leading causes of cancer related death in the world. Biannual surveillance for the disease in patients with cirrhosis and in high risk carriers of hepatitis B virus allows early stage cancer detection and treatment with good long term outcomes. Liver ultrasonography and serum α fetoprotein are the most commonly used surveillance tests. If suspicious results are found on the surveillance test, multiphasic computed tomography or magnetic resonance imaging should be undertaken to confirm the diagnosis of hepatocellular carcinoma. If radiologic tests show inconclusive results, liver biopsy or repeat imaging could be considered for confirmation of hepatocellular carcinoma. Management of the disease is complex. Patients should be evaluated by a multidisciplinary team, and the selection of treatment should consider factors such as tumor burden, severity of liver dysfunction, medical comorbidities, local expertise, and preference of patients. Early stage hepatocellular carcinoma is best managed by curative treatment, which includes resection, ablation, or transplantation. Patients with intermediate stage disease often receive locoregional treatment. Systemic treatment is reserved for patients with advanced disease. Several positive, phase III, randomized controlled trials have expanded the systemic treatment options for advanced hepatocellular carcinoma with promising long term outcomes, especially trials using combination treatments, which could also have eventual implications for the treatment of earlier stage disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Self-citationEl-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Self-citationBruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Zhu, A. X., Finn, R. S., Edeline, J., Cattan, S., Ogasawara, S., Palmer, D., Verslype, C., Zagonel, V., Fartoux, L., Vogel, A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30351-6 · Cited by 2,479
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Finn, R. S., Ryoo, B.-Y., Merle, P., Kudo, M., Bouattour, M., Lim, H. Y., Breder, V., Edeline, J., Chao, Y., Ogasawara, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01307 · Cited by 1,789
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A. K., & Singal, A. G. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.064 · Cited by 1,207
Bruix, J., Takayama, T., Mazzaferro, V., Chau, G.-Y., Yang, J., Kudo, M., Cai, J., Poon, R. T., Han, K.-H., Tak, W. Y., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00198-9 · Cited by 1,120
Self-citationClavien, P.-A., Lesurtel, M., Bossuyt, P. M., Gores, G. J., Langer, B., & Perrier, A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70175-9 · Cited by 1,026
Epidemiology and natural history of HCV infection
Hajarizadeh, B., Grebely, J., & Dore, G. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.107 · Cited by 994
Livraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., & Torzilli, G. (1995) · Radiology · doi:10.1148/radiology.197.1.7568806 · Cited by 939
Huang, J., Yan, L., Cheng, Z., Wu, H., Du, L., Wang, J., Xu, Y., & Zeng, Y. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181efc656 · Cited by 844
Singal, A. G., Pillai, A., & Tiro, J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001624 · Cited by 817
Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease
Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795
Cheng, A.-L., Kang, Y.-K., Lin, D.-Y., Park, J.-W., Kudo, M., Qin, S., Chung, H.-C., Song, X., Xu, J., Poggi, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8372 · Cited by 777
Johnson, P. J., Qin, S., Park, J.-W., Poon, R. T. P., Raoul, J.-L., Philip, P. A., Hsu, C.-H., Hu, T.-H., Heo, J., Xu, J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4410 · Cited by 772
Feng, K., Yan, J., Li, X., Xia, F., Ma, K., Wang, S., Bie, P., & Dong, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.007 · Cited by 767
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Ramjiawan, R. R., Griffioen, A. W., & Duda, D. G. (2017) · Angiogenesis · doi:10.1007/s10456-017-9552-y · Cited by 672
Yau, T., Park, J. W., Finn, R. S., Cheng, A.-L., Mathurin, P., Edeline, J., Kudo, M., Han, K.-H., Harding, J. J., Merle, P., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz394.029 · Cited by 647
Zhu, A. X., Rosmorduc, O., Evans, T. R. J., Ross, P. J., Santoro, A., Carrilho, F. J., Bruix, J., Qin, S., Thuluvath, P. J., Llovet, J. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.7746 · Cited by 576
Ioannou, G. N., Green, P. K., & Berry, K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.030 · Cited by 573
Yao, F. Y., Xiao, L., Bass, N. M., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01965.x · Cited by 562
Papatheodoridis, G., Dalekos, G., Sypsa, V., Yurdaydin, C., Buti, M., Goulis, J., Calleja, J. L., Chi, H., Manolakopoulos, S., Mangia, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.035 · Cited by 557
Kokudo, T., Hasegawa, K., Matsuyama, Y., Takayama, T., Izumi, N., Kadoya, M., Kudo, M., Ku, Y., Sakamoto, M., Nakashima, O., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.044 · Cited by 491
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
Hegde, P. S., Wallin, J. J., & Mancao, C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.002 · Cited by 453
Yoon, S. M., Ryoo, B.-Y., Lee, S. J., Kim, J. H., Shin, J. H., An, J. H., Lee, H. C., & Lim, Y.-S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5847 · Cited by 446
Marrero, J. A., Kudo, M., Venook, A. P., Ye, S.-L., Bronowicki, J.-P., Chen, X.-P., Dagher, L., Furuse, J., Geschwind, J.-F. H., de Guevara, L. L., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.020 · Cited by 385
OPTN/SRTR 2018 Annual Data Report: Liver
Kwong, A., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Foutz, J., Miller, E., Snyder, J. J., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15674 · Cited by 385
Brown, K. T., Do, R. K., Gonen, M., Covey, A. M., Getrajdman, G. I., Sofocleous, C. T., Jarnagin, W. R., D’Angelica, M. I., Allen, P. J., Erinjeri, J. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0821 · Cited by 380
Sapisochin, G., Goldaracena, N., Laurence, J. M., Dib, M., Barbas, A., Ghanekar, A., Cleary, S. P., Lilly, L., Cattral, M. S., Marquez, M., et al. (2016) · Hepatology · doi:10.1002/hep.28643 · Cited by 368
Loomba, R., Lim, J. K., Patton, H., & El-Serag, H. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.053 · Cited by 357
Kim, S. Y., An, J., Lim, Y.-S., Han, S., Lee, J.-Y., Byun, J. H., Won, H. J., Lee, S. J., Lee, H. C., & Lee, Y. S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3147 · Cited by 356
Non-invasive diagnosis of liver fibrosis and cirrhosis
Lurie, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11567 · Cited by 352
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., Morse, J., Hull, D., Patman, G., Kagebayashi, C., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0870 · Cited by 350
Ahn, J. C., Teng, P., Chen, P., Posadas, E., Tseng, H., Lu, S. C., & Yang, J. D. (2021) · Hepatology · doi:10.1002/hep.31165 · Cited by 338
Self-citationYin, L., Li, H., Li, A.-J., Lau, W. Y., Pan, Z.-Y., Lai, E. C. H., Wu, M.-C., & Zhou, W.-P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.012 · Cited by 334
Ng, K. K. C., Chok, K. S. H., Chan, A. C. Y., Cheung, T. T., Wong, T. C. L., Fung, J. Y. Y., Yuen, J., Poon, R. T. P., Fan, S. T., & Lo, C. M. (2017) · British Journal of Surgery · doi:10.1002/bjs.10677 · Cited by 331
Simmons, O., Fetzer, D. T., Yokoo, T., Marrero, J. A., Yopp, A., Kono, Y., Parikh, N. D., Browning, T., & Singal, A. G. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13841 · Cited by 328
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., Schweitzer, N., Vogel, A., Manns, M. P., Benckert, J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.042 · Cited by 323
Vietti Violi, N., Duran, R., Guiu, B., Cercueil, J.-P., Aubé, C., Digklia, A., Pache, I., Deltenre, P., Knebel, J.-F., & Denys, A. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30029-3 · Cited by 302
Kulik, L., Heimbach, J. K., Zaiem, F., Almasri, J., Prokop, L. J., Wang, Z., Murad, M. H., & Mohammed, K. (2018) · Hepatology · doi:10.1002/hep.29485 · Cited by 298
Self-citationBest, J., Bechmann, L. P., Sowa, J.-P., Sydor, S., Dechêne, A., Pflanz, K., Bedreli, S., Schotten, C., Geier, A., Berg, T., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.012 · Cited by 288
Pompili, M., Saviano, A., de Matthaeis, N., Cucchetti, A., Ardito, F., Federico, B., Brunello, F., Pinna, A. D., Giorgio, A., Giulini, S. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.009 · Cited by 285
Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
Kudo, M., Matsui, O., Izumi, N., Kadoya, M., Okusaka, T., Miyayama, S., Yamakado, K., Tsuchiya, K., Ueshima, K., Hiraoka, A., et al. (2014) · Oncology · doi:10.1159/000368142 · Cited by 283
Toso, C., Meeberg, G., Hernandez‐Alejandro, R., Dufour, J., Marotta, P., Majno, P., & Kneteman, N. M. (2015) · Hepatology · doi:10.1002/hep.27787 · Cited by 281
Fisher, R. A., Kulik, L. M., Freise, C. E., Lok, A. S. F., Shearon, T. H., Brown, R. S., Ghobrial, R. M., Fair, J. H., Olthoff, K. M., Kam, I., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01802.x · Cited by 272
Vouche, M., Lewandowski, R. J., Atassi, R., Memon, K., Gates, V. L., Ryu, R. K., Gaba, R. C., Mulcahy, M. F., Baker, T., Sato, K., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.015 · Cited by 271
Serper, M., Taddei, T. H., Mehta, R., D’Addeo, K., Dai, F., Aytaman, A., Baytarian, M., Fox, R., Hunt, K., Goldberg, D. S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.040 · Cited by 265
Terzi, E., Iavarone, M., Pompili, M., Veronese, L., Cabibbo, G., Fraquelli, M., Riccardi, L., De Bonis, L., Sangiovanni, A., Leoni, S., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.007 · Cited by 259
Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma
Bouattour, M., Raymond, E., Qin, S., Cheng, A., Stammberger, U., Locatelli, G., & Faivre, S. (2018) · Hepatology · doi:10.1002/hep.29496 · Cited by 257
Chen, J., Jin, R., Zhao, J., Liu, J., Ying, H., Yan, H., Zhou, S., Liang, Y., Huang, D., Liang, X., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.019 · Cited by 251
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
Lewandowski, R. J., Gabr, A., Abouchaleh, N., Ali, R., Al Asadi, A., Mora, R. A., Kulik, L., Ganger, D., Desai, K., Thornburg, B., et al. (2018) · Radiology · doi:10.1148/radiol.2018171768 · Cited by 251
Salem, R., Gabr, A., Riaz, A., Mora, R., Ali, R., Abecassis, M., Hickey, R., Kulik, L., Ganger, D., Flamm, S., et al. (2018) · Hepatology · doi:10.1002/hep.29691 · Cited by 236
Yau, T., Kang, Y.-K., Kim, T.-Y., El-Khoueiry, A. B., Santoro, A., Sangro, B., Melero, I., Kudo, M., Hou, M.-M., Matilla, A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.4012 · Cited by 229
Yang, J. D., Addissie, B. D., Mara, K. C., Harmsen, W. S., Dai, J., Zhang, N., Wongjarupong, N., Ali, H. M., Ali, H. A., Hassan, F. A., et al. (2019) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0281 · Cited by 222
Self-citationLo, C. M., Fan, S. T., Liu, C. L., Chan, S. C., Ng, I. O.-L., & Wong, J. (2007) · Journal of British Surgery · doi:10.1002/bjs.5528 · Cited by 213
Kisiel, J. B., Dukek, B. A., V.S.R. Kanipakam, R., Ghoz, H. M., Yab, T. C., Berger, C. K., Taylor, W. R., Foote, P. H., Giama, N. H., Onyirioha, K., et al. (2019) · Hepatology · doi:10.1002/hep.30244 · Cited by 210
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Teufel, M., Seidel, H., Köchert, K., Meinhardt, G., Finn, R. S., Llovet, J. M., & Bruix, J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.261 · Cited by 202
Sapir, E., Tao, Y., Schipper, M. J., Bazzi, L., Novelli, P. M., Devlin, P., Owen, D., Cuneo, K. C., Lawrence, T. S., Parikh, N. D., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.09.001 · Cited by 197
Rim, C. H., Kim, H. J., & Seong, J. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.12.005 · Cited by 196
Northup, P. G., Intagliata, N. M., Shah, N. L., Pelletier, S. J., Berg, C. L., & Argo, C. K. (2015) · Hepatology · doi:10.1002/hep.27283 · Cited by 188
Kaido, T., Ogawa, K., Mori, A., Fujimoto, Y., Ito, T., Tomiyama, K., Takada, Y., & Uemoto, S. (2013) · Surgery · doi:10.1016/j.surg.2013.04.056 · Cited by 175
Cheung, T. T., Dai, W. C., Tsang, S. H. Y., Chan, A. C. Y., Chok, K. S. H., Chan, S. C., & Lo, C. M. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001848 · Cited by 174
Shiina, S., Sato, K., Tateishi, R., Shimizu, M., Ohama, H., Hatanaka, T., Takawa, M., Nagamatsu, H., & Imai, Y. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/4756147 · Cited by 173
Pocha, C., Dieperink, E., McMaken, K. A., Knott, A., Thuras, P., & Ho, S. B. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12370 · Cited by 171
Mehta, N., Guy, J., Frenette, C. T., Dodge, J. L., Osorio, R. W., Minteer, W. B., Roberts, J. P., & Yao, F. Y. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.11.037 · Cited by 170
Hara, K., Takeda, A., Tsurugai, Y., Saigusa, Y., Sanuki, N., Eriguchi, T., Maeda, S., Tanaka, K., & Numata, K. (2019) · Hepatology · doi:10.1002/hep.30591 · Cited by 164
Sposito, C., Battiston, C., Facciorusso, A., Mazzola, M., Muscarà, C., Scotti, M., Romito, R., Mariani, L., & Mazzaferro, V (2016) · British Journal of Surgery · doi:10.1002/bjs.10137 · Cited by 160
Poustchi, H., Farrell, G. C., Strasser, S. I., Lee, A. U., McCaughan, G. W., & George, J. (2010) · Hepatology · doi:10.1002/hep.24581 · Cited by 158
Kulik, L., Fisher, R. A., Rodrigo, D. R., Brown, R. S., Freise, C. E., Shaked, A. A., Everhart, J., Everson, G. T., Hong, J. C., Hayashi, P. H., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04272.x · Cited by 153
Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance
Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Chaiteerakij, R., Enders, F., Therneau, T. M., Orsini, L. S., Kim, W. R., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.027 · Cited by 132
Self-citationHepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis
Choi, D. T., Kum, H., Park, S., Ohsfeldt, R. L., Shen, Y., Parikh, N. D., & Singal, A. G. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.031 · Cited by 130
Weis, S., Franke, A., Mössner, J., Jakobsen, J. C., & Schoppmeyer, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003046.pub3 · Cited by 124
Liu, H., Wang, Z.-G., Fu, S.-Y., Li, A.-J., Pan, Z.-Y., Zhou, W.-P., Wy, L., & Wu, M.-C. (2016) · British journal of surgery · doi:10.1002/bjs.10061 · Cited by 124
Goldaracena, N., Gorgen, A., Doyle, A. C., Hansen, B. E., Tomiyama, K., Zhang, W., Ghanekar, A., Lilly, L. B., Cattral, M. S., Galvin, Z., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.029 · Cited by 119
Kim, H., An, J., Park, J., Park, S., Lim, Y., & Lee, E. (2019) · Hepatology · doi:10.1002/hep.30330 · Cited by 114
Allocation of liver grafts worldwide – Is there a best system?
Tschuor, C., Ferrarese, A., Kuemmerli, C., Dutkowski, P., Burra, P., Clavien, P., Lendoire, J. C., Imventarza, O., Crawford, M., Andraus, W., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.025 · Cited by 114
Liu, W., Zheng, Y., He, W. A., Zou, R., Qiu, J., Shen, J., Yang, Z., Zhang, Y., Wang, C., Wang, Y., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14929 · Cited by 113
Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States
Rich, N. E., Yopp, A. C., Singal, A. G., & Murphy, C. C. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.043 · Cited by 113
Llovet, J. M., Kudo, M., Cheng, A., Finn, R. S., Galle, P. R., Kaneko, S., Meyer, T., Qin, S., Dutcus, C. E., Chen, E., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.tps4152 · Cited by 112
Perumpail, R. B., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3821-7 · Cited by 111
Kambhampati, S., Bauer, K., Bracci, P. M., Keenan, B. P., Behr, S. C., Gordan, J. D., & Kelley, R. K. (2019) · Cancer · doi:10.1002/cncr.32206 · Cited by 105
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn, D. H., Choi, G., Park, H. C., Kim, J. M., Kim, H., Song, K. D., Kang, T. W., Lee, M. W., Rhim, H., Hyun, D., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210730 · Cited by 100
Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma
Gabr, A., Abouchaleh, N., Ali, R., Baker, T., Caicedo, J. C., Katariya, N., Abecassis, M. M., Riaz, A., Lewandowski, R. J., & Salem, R. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2018.06.027 · Cited by 98
Cheng, A., Amarapurkar, D. N., Chao, Y., Chen, P., Geschwind, J.-F. H., Goh, K., Han, K., Kudo, M., Lee, H. C., Lee, R., et al. (2013) · Liver International · doi:10.1111/liv.12314 · Cited by 89
Khatri, G., Pedrosa, I., Ananthakrishnan, L., de Leon, A. D., Fetzer, D. T., Leyendecker, J. R., Singal, A. G., Xi, Y., Yopp, A. C., & Yokoo, T. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26835 · Cited by 88
Facciorusso, A., Bellanti, F., Villani, R., Salvatore, V., Muscatiello, N., Piscaglia, F., Vendemiale, G., & Serviddio, G. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616673516 · Cited by 86
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Hanouneh, I. A., Alkhouri, N., & Singal, A. G. (2019) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2019.1001 · Cited by 71
Kim, R., Kang, T. W., Cha, D. I., Song, K. D., Lee, M. W., Rhim, H., Lim, H. K., & Sinn, D. H. (2018) · European Radiology · doi:10.1007/s00330-018-5617-6 · Cited by 69
Llovet, J. M., Shepard, K., Finn, R., Ikeda, M., Sung, M. W., Baron, A. D., Kudo, M., Okusaka, T., Kobayashi, M., Kumada, H., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz247.073 · Cited by 67
Chong, J. U., Choi, G. H., Han, D. H., Kim, K. S., Seong, J., Han, K., & Choi, J. S. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6653-9 · Cited by 61
Yang, J. D., Mannalithara, A., Piscitello, A. J., Kisiel, J. B., Gores, G. J., Roberts, L. R., & Kim, W. R. (2017) · Hepatology · doi:10.1002/hep.29594 · Cited by 61
Self-citationWong, T. C.-L., Ng, K. K., Fung, J., Chan, A. C. Y., Cheung, T. T., Chok, K., Dai, J. W.-C., & Lo, C. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07206-0 · Cited by 61
Impact of a Single-Day Multidisciplinary Clinic on the Management of Patients with Liver Tumours
Zhang, J., Mavros, M. N., Cosgrove, D., Hirose, K., Herman, J. M., Smallwood–Massey, S., Kamel, I. R., Gurakar, A. O., Anders, R. A., Cameron, A. M., et al. (2013) · Current Oncology · doi:10.3747/co.20.1297 · Cited by 60
Li, J., Shi, L., Zhang, X., Sun, B., Yang, Y., Ge, N., Liu, H., Yang, X., Chen, L., Qian, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6104 · Cited by 55
Tian, G., Yang, S., Yuan, J.-Q., Threapleton, D. E., Zhao, Q., Chen, F., Cao, H., Jiang, T., & Li, L. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021269 · Cited by 55
Recent Decline in Hepatocellular Carcinoma Rates in the United States
Shiels, M. S., & OʼBrien, T. R. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.030 · Cited by 53
Liang, L., Chen, T., Li, C., Xing, H., Han, J. S., Wang, M.-D., Zhang, H., Lau, W. Y., Wu, M., Shen, F., et al. (2018) · HPB · doi:10.1016/j.hpb.2018.06.1804 · Cited by 47
Labgaa, I., Tabrizian, P., Titano, J. J., Kim, E., Thung, S. N., Florman, S. S., Schwartz, M., & Melloul, E. (2019) · HPB · doi:10.1016/j.hpb.2019.03.360 · Cited by 46
Circulating Tumor DNA and Hepatocellular Carcinoma
Yang, J. D., Liu, M., & Kisiel, J. B. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688503 · Cited by 46
Self-citationKelley, R. K., Cheng, A., Braiteh, F. S., Park, J., Benzaghou, F., Milwee, S., Borgman, A. E., El-Khoueiry, A. B., Kayali, Z. K., Zhu, A. X., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.tps4157 · Cited by 33
Cited by
Yeo, Y. H., Samaan, J. S., Ng, W. H., Ting, P.-S., Trivedi, H., Vipani, A., Ayoub, W., Yang, J. D., Liran, O., Spiegel, B., et al. (2023) · doi:10.1101/2023.02.06.23285449 · Cited by 666
Self-citationYeo, Y. H., Samaan, J. S., Ng, W. H., Ting, P.-S., Trivedi, H., Vipani, A., Ayoub, W., Yang, J. D., Liran, O., Spiegel, B., et al. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0089 · Cited by 662
Self-citationHepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Hwang, S. Y., Danpanichkul, P., Agopian, V., Mehta, N., Parikh, N. D., Abou-Alfa, G. K., Singal, A. G., & Yang, J. D. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0824 · Cited by 306
Self-citation
Metadata
- Authors
- Yang, J. D., & Heimbach, J. K.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2020-10-26
- Volume
- 371
- Pages
- m3544
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3094276961
- Cited by
- 384
- References
- 121
- FWCI
- 30.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.